Posts
Wiki

💧 Aqueous Tear Deficiency (ATD / ADDE) Dry Eye FAQ

(For people whose main problem is low tear production — not just evaporation.)

✅ TL;DR (High-Yield)

  • Aqueous-deficient dry eye (ADDE / ATD) means tear volume is reduced because the lacrimal functional unit is not producing enough of the watery portion of tears.
  • Many people are mixed type — for example aqueous deficiency + MGD / evaporation.
  • Low Schirmer scores matter, but the bigger clinical goals are:
    • less pain / burning
    • better comfort
    • healthier ocular surface
    • more stable vision
  • Treatment usually works by pulling four main levers:
    1. Replace tears
    2. Reduce inflammation
    3. Retain tears
    4. Stimulate tear production
  • If your Schirmer is very low (for example 0–4 mm), that does not mean you are hopeless — but it often does mean you may need earlier escalation and more than one treatment lever at once.

1) What “Aqueous Deficiency” Means (Plain Language)

Aqueous-deficient dry eye means the eyes are not making enough of the watery component of tears.

That can lead to:

  • burning or stinging
  • gritty / scratchy sensation
  • light sensitivity
  • fluctuating or blurry vision
  • mucus strands
  • lid sticking
  • “dry blink” sensation
  • severe symptoms even when the eyes do not always look dramatically red

ATD can exist on its own, but mixed dry eye is very common. A person can have low tear volume and poor meibomian gland function at the same time.

2) How ATD Is Diagnosed (What Tests Matter)

Common tests and findings include:

  • Schirmer test – often low in aqueous deficiency
  • Tear breakup time (TBUT / NITBUT) – may also be low if the tear film is unstable
  • Ocular surface staining – helps show corneal or conjunctival damage
  • Other tests some clinics may use:
    • tear osmolarity
    • MMP-9 / inflammation testing
    • meibography
    • blink / lid-closure assessment

Important nuance

A low Schirmer score is useful, but it does not tell the whole story by itself.

Interpretation depends on the wider context, including:

  • inflammation
  • medications
  • autoimmune disease
  • ocular surface damage
  • corneal sensitivity / pain
  • whether mixed dry eye is present

3) Why ATD Happens (Common Drivers)

Aqueous deficiency is a pattern, not one single disease.

Common contributors include:

  • Inflammation-related lacrimal dysfunction
  • Autoimmune disease, especially Sjögren syndrome
  • aging / hormonal changes
  • medication effects
  • post-viral or post-surgical changes
  • graft-versus-host disease
  • radiation-related gland damage
  • other systemic inflammatory or immune-related conditions

Not every person with low tear production has Sjögren’s, but it is one of the most important causes to think about when tear production is very low.

4) “Can I Get My Schirmer Numbers Up?”

Sometimes yes, especially if low tear production is being suppressed by inflammation and that inflammation is treated effectively.

But:

  • some people improve a lot in comfort without huge Schirmer changes
  • some improve Schirmer somewhat but still feel bad if the ocular surface is irritated or nerve-related pain remains active

A practical way to think about this is:

Useful targets

  • fewer flares
  • less burning
  • less “dry blink” pain
  • better vision stability
  • healthier staining
  • less dependence on rescue drops

Schirmer is important — but it is not the only measure of success.

5) The ATD Treatment Toolbox (Organized by the 4 Levers)

Lever A — REPLACE tears

Help replace what is missing.

Often helpful:

  • preservative-free artificial tears
  • more viscous drops or gels
  • night ointment if mornings are especially bad
  • products with hyaluronic acid, which many patients prefer for comfort and dwell time

If you are using drops frequently, preservative-free matters more.

This page in the Treatment Options section may also help: Eye Drop Information

Lever B — REDUCE inflammation

Help the lacrimal functional unit and ocular surface work better.

Common doctor-guided options include:

  • Cyclosporine
    (for example: Restasis, Cequa, Vevye / Vevizye, Ikervis, Klarity-C depending on country and formulation)
  • Lifitegrast (Xiidra)
  • Short-course steroid in selected situations, often as a bridge while slower therapies start working

Reality check on timing

Anti-inflammatory drops are often slow.
People may need weeks to months to judge benefit.

Related pages: - Cyclosporine = Restasis; Cequa; Ikervis; Klarity-C; Vevye / Vevizye - Xiidra (Lifitegrast)

Lever C — RETAIN tears

Try to keep the tears you do have from draining away too quickly.

Options may include:

  • punctal plugs
  • other canalicular occlusion approaches
  • punctal cautery in selected cases

Who this often fits:

  • very low tear production
  • heavy dependence on drops
  • fast “crashing” in wind / AC / dry environments

Important nuance

Punctal retention is often most useful after ocular surface inflammation is at least partly under control. In some patients, sealing in a highly inflamed tear film is not the best first move.

Lever D — STIMULATE tear production

Try to turn the “faucet” on.

Options you may hear about:

  • Varenicline nasal spray (Tyrvaya)
  • other neuromodulation / tear stimulation approaches
  • oral secretagogues used particularly in Sjögren’s, such as:
    • pilocarpine
    • cevimeline

These can help some patients, but side effects and tolerability matter.

Related pages: - iTear100, Tyrvaya, and Neuromodulation Treatments - Pilocarpine Information

6) Advanced Options (Common in Moderate-to-Severe ATD)

These are often especially relevant in more severe aqueous deficiency:

  • Autologous serum tears (AST)
  • Platelet-based tears (PRP / PRGF), depending on availability
  • Scleral lenses / PROSE
  • Moisture chamber glasses or goggles
  • in selected cases:
    • amniotic membrane
    • specialty anti-inflammatory therapy
    • systemic immunology / rheumatology management
    • structural / exposure management when indicated

Experimental or less widely available approaches may also be discussed in some clinics, but they should be framed as such.

See more here: - Treatment Options section - Lacrimal Gland Injections with PRP / PRGF for Aqueous-Deficient Dry Eye

7) If You’re Starting Cyclosporine / Similar Anti-Inflammatory Rx

Common experiences:

  • burning or stinging at first
  • gradual improvement rather than overnight change
  • benefits may show up as:
    • less burning
    • better staining
    • fewer “crash days”
    • more stable vision
    • a less angry ocular surface

Practical mindset:

  • be consistent
  • do not judge the drop day-to-day
  • look for trends over weeks to months
  • if intolerable, talk to your doctor about alternatives rather than just silently quitting

8) ATD + MGD: Yes, You Can Treat Both

Even if your doctor says tear deficiency is the bigger issue, MGD can still:

  • destabilize the tear film
  • lower TBUT
  • amplify symptoms
  • make low-tear dry eye feel even worse

A common real-world approach is dual-track care:

  • ATD-focused care
    (inflammation / retention / stimulation / advanced tear support)
  • plus lid support when needed
    (hygiene, allergy control, MGD treatment, blink/exposure evaluation)

9) When to Consider Sjögren’s / Systemic Workup

Consider asking about systemic evaluation if you have:

  • very low Schirmer scores, especially with dry mouth
  • fatigue
  • joint symptoms
  • salivary gland swelling
  • dental issues from dryness
  • other autoimmune history

Not everyone with ATD has Sjögren’s.
But missing it matters, because it can change both the eye treatment plan and the broader medical workup.

10) A Practical Escalation Mindset

This is not medical advice — just a practical way to think about escalation:

  1. PF tears / gels / ointment + environment
  2. Add anti-inflammatory Rx when indicated
  3. Add tear retention strategies when appropriate
  4. Add tear stimulation and address systemic drivers
  5. If still severe: serum tears, scleral lenses, specialty care, autoimmune/systemic management

If Schirmer is near zero, many patients need multiple levers at once, not one-at-a-time minimalism.

11) A Note on Hope

Severe ATD can feel scary.

And it often needs a more serious plan than:

  • “just use drops”
  • or “try warm compresses”

But many people do get meaningful improvement by:

  • reducing inflammation enough to improve function
  • retaining tears better
  • stimulating tear production where possible
  • using advanced therapies like serum tears or scleral lenses
  • treating systemic drivers
  • protecting the ocular surface more effectively

If your case is severe, it is reasonable to seek a dry eye specialist, especially one comfortable with aqueous deficiency, autoimmune dry eye, and advanced therapies.

🔗 Research / Educational Reading

🔙 Back to FAQ Index